ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,527.20
      1.07%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,901.04
      3.21%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. 10x Genomics Inc (TXG)

      7. 10x Genomics Inc (TXG) Financials

      10x Genomics Inc

      10x Genomics Inc (TXG)

      Terex Corp.
      Torex Gold Resources Inc
      20.22
      0.30
      (1.51%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      20.22
      0.00
      ( 0.00% )
      After Hours: 6:55PM
      Delayed by 15 minutes

      10x Genomics Inc Financial Summary

      The current TXG market cap is 2.42B. The company's latest EPS is USD -2.1310 and P/E is -9.49.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 134.29M146.82M153.64M183.98M141.01M
      Operating Income -51.99M-63.36M-94.8M-50.29M-61.5M
      Net Income -50.75M-62.41M-92.99M-48.95M-59.95M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 245.89M298.85M491.15M516.41M618.73M
      Operating Income -30.57M-534.14M-52.25M-167.94M-260.43M
      Net Income -31.25M-542.73M-58.22M-166M-255.1M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.01B989.64M948.54M965.14M922.91M
      Total Liabilities 211.65M196.34M203.32M224.1M204.08M
      Total Equity 802.39M793.3M745.22M741.04M718.83M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 605.92M929.34M1.02B1.03B965.14M
      Total Liabilities 185.84M190.27M201.26M223.24M224.1M
      Total Equity 420.08M739.07M817.57M805.74M741.04M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -4.13M-15.65M-40.96M-15.2M-15.73M
      Investing 119.96M115.49M120.39M133.49M10.63M
      Financing -3.41M3.68M8.06M13.67M1.64M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 34.63M-217.9M-21.37M-33.61M-15.2M
      Investing -42.77M-38.39M-106.73M-350.89M133.49M
      Financing 414.59M468.91M35.3M15.82M13.67M

      Stats and Ratios

      Market Cap 2.42B
      Price to Earnings Ratio -9.49
      Price to Sales Ratio 3.91
      Price to Cash Ratio 6.74
      Price to Book Ratio 3.27
      Dividend Yield -

      Share Statistics

      Shares Outstanding 119.71M
      Average Volume (1 week) 2.49M
      Average Volume (1 Month) 2.59M
      52 Week Change -66.53%
      52 Week High 63.57
      52 Week Low 15.28
      Spread (Intraday) 0.03 (0.15%)

      Company Info

      Company Name 10x Genomics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.10xgenomics.com
      Industry lab analytical instruments (3826)